Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Wei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5701-3230; OpenAlex author ID A5100317968. Sources: OpenAlex.

Their work

Papers
24 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
71
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 2 papers · 2014: 3 papers · 2015: 2 papers · 2016: 5 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 24

  1. Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Co-author DOI 10.1016/j.cellsig.2024.111381↗
  2. Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Co-author DOI 10.1002/cam4.5871↗
  3. Piezo1 act as a potential oncogene in pancreatic cancer progression. First author DOI 10.1016/j.lfs.2022.121035↗
  4. Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinom… Co-author DOI 10.1097/sla.0000000000004993↗
  5. Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions. Co-author DOI 10.1016/j.isci.2021.103400↗
  6. Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency. Last author DOI 10.1016/j.jconrel.2020.06.001↗
  7. Cav-1 Ablation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Growth through Nrf2-Induced shh Signaling. Co-author DOI 10.1155/2020/1868764↗
  8. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer. Co-author DOI 10.1016/j.csbj.2018.10.006↗
  9. Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-κB pathway in pancreatic cancer cells. Co-author DOI 10.3892/ijo.2018.4295↗
  10. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. Co-author DOI 10.1155/2016/1616781↗
  11. The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. Co-author DOI 10.1155/2016/3897250↗
  12. Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide. Co-author DOI 10.1155/2016/5190314↗
  13. Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Co-author DOI 10.1155/2016/6815727↗
  14. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway. Last author DOI 10.3892/or.2016.5044↗
  15. Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer. Co-author DOI 10.1080/15384047.2015.1040952↗
  16. Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer. Co-author DOI 10.18632/oncotarget.5045↗
  17. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Co-author DOI 10.1016/j.canlet.2014.02.003↗
  18. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-3426↗
  19. Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway. Co-author DOI 10.3892/mmr.2014.2511↗
  20. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells. Co-author DOI 10.1158/1541-7786.mcr-12-0609↗
  21. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells. Co-author DOI 10.2174/09298673113209990249↗
  22. The bidirectional interation between pancreatic cancer and diabetes. Co-author DOI 10.1186/1477-7819-10-171↗
  23. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. Co-author DOI 10.1371/journal.pone.0017385↗
  24. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. Co-author DOI 10.1371/journal.pone.0027074↗

Closest collaborators

The 25 strongest of 71 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 20 shared papers, 2011–2024 · strength 1.34
  2. Zheng Wu · 5 shared papers, 2018–2024 · strength 0.67
  3. Wanxing Duan · 10 shared papers, 2013–2022 · strength 0.59
  4. Weikun Qian · 4 shared papers, 2018–2022 · strength 0.45
  5. Qinhong Xu · 10 shared papers, 2011–2018 · strength 0.44
  6. Xuqi Li · 8 shared papers, 2013–2020 · strength 0.40
  7. Liang Han · 5 shared papers, 2013–2021 · strength 0.38
  8. Erxi Wu · 9 shared papers, 2011–2020 · strength 0.38
  9. Zheng Wang · 3 shared papers, 2013–2024 · strength 0.34
  10. Cancan Zhou · 2 shared papers, 2022–2024 · strength 0.34
  11. Liang Han · 7 shared papers, 2011–2022 · strength 0.34
  12. Jianjun Lei · 6 shared papers, 2014–2020 · strength 0.32
  13. Lun Zhang · 5 shared papers, 2016 · strength 0.30
  14. Jiguang Ma · 6 shared papers, 2013–2018 · strength 0.28
  15. Zhengdong Jiang · 4 shared papers, 2016–2018 · strength 0.26
  16. Zheng Wang · 2 shared papers, 2018–2021 · strength 0.22
  17. Liang Zong · 4 shared papers, 2016 · strength 0.22
  18. Jiantao Mo · 1 shared paper, 2024 · strength 0.21
  19. Ruiqi Cao · 1 shared paper, 2024 · strength 0.21
  20. Lei Cao · 2 shared papers, 2016–2018 · strength 0.17
  21. Han Liu · 5 shared papers, 2011–2014 · strength 0.16
  22. Zhenhua Ma · 3 shared papers, 2014–2016 · strength 0.15
  23. Tao Shan · 3 shared papers, 2016 · strength 0.15
  24. Shuang Si · 1 shared paper, 2023 · strength 0.15
  25. Zhuzeng Yin · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.